ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Dólar dos Estados Unidos por Dólares Nova Zelândia - Fevereiro 2025

Dólar dos Estados Unidos por Dólares Nova Zelândia - Fevereiro 2025 (NZLG25)

556.10
-3.70
(-0.66%)
마감 13 1월 6:25AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

NZLG25 뉴스

공식 뉴스 전용
0개의 기사가 발견되었습니다.
tw0122 tw0122 9 분 전
$4.24 target one reached 
UVIX
FranCoRazon FranCoRazon 9 분 전
If it was correct yes. But there are a lot of assumptions and even more details not mentioned. People get more and more fooled by AI just like google.
LWLG
Wayne R Wayne R 23 분 전
It's a fashion statement and ecologically friendly
Investor2014 Investor2014 27 분 전
Whether you like it or not, it is a fact that in May 120 days will have passed since the CHMP accepted the Anavex MAA. That will be clock stop one in the EMA process, where it is highly unlikely there will no questions raised for Anavex to reply to and for which 90 days are available.

AVXL
ducci1 ducci1 30 분 전
Pivot Calcs: SPX Pivot--5841----R1--5875----R2--5924-----S1--5792----S2--5758----SPY Pivot--581----R1--584----S1--576-----Vix Pivot--19.30----R1--2055----R2--21.56----R3--23.82----S1--18.29 !!LOL!!
SPY
meshcan meshcan 31 분 전
Nobody forcing you to stay here unless you want and you most likely are benefiting from bashing Elite or shorting or day trading...otherwise what you are saying doesn't make sense.

I know many longs here are already millionaire with current price, ~0.5 pps, but I'm sure they are waiti
ELTP
along4zride along4zride 31 분 전
Get ready to be thrown under (FNMA) bus .
No way no how slick suit and haircut Wall Street huckster gives one cent care about hopeful investor. More than likely common share holder has been ginned up . Sheep ready for slaughter or should I say vultures .

FNMA
jxyzobrien jxyzobrien 38 분 전
tangerine Mussolini
Killing the market
layoffs all over
tariff news has not yet brought in long term sellers
market should be up sunday nite NOPE
Hi_Lo Hi_Lo 47 분 전
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents scamming pumpers and liars like you from making profits by creating bagholders here. And that's part of my goal - and to h
BCAP
DiamondHealer95 DiamondHealer95 51 분 전
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 57 분 전
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 1 시간 전
We've invested similarly
KBLB
sunspotter sunspotter 1 시간 전
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 1 시간 전
Marc loved your ides
tinojax tinojax 1 시간 전
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 1 시간 전
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 2 시간 전
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 2 시간 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 2 시간 전
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

최근 히스토리

Delayed Upgrade Clock